A2-Ai
Home
LeadershipBlogCareersGet in touch
Home
LeadershipBlogCareersGet in touch
All posts Tag / FDA

Categories

case studiesnewsproductsresearch spotlightsservicestoolingupdates

Tags

2025ADMEAgingAIanimal testingAnnualapproval processCardiac Safetyclinical pharmacologyClinical PharmacologyClinical Researchclinical trials
RSS See all filters
news

MIDD - FDA Has Officially Announced Their Roadmap to Phase Out Animal Testing for Monoclonal Antibodies

Simonne Bruck April 30, 2025
servicescase studies

Accelerating FDA Approval with MIDD: How A2-Ai Secured a New Dose Without a Phase 3 Trial

Eric Storms November 14, 2025
services

IND Services - We Support and Assist You in IND Applications to Streamline the FDA Approval Process

Simonne Bruck February 28, 2025

Links

Home Leadership Blog Careers Contact

Solutions

A2-Ai Cloud Alexandria PRISM Sage AI

Science Services

FDA Project Optimus Preclinical Support Clinical Pharmacology Pharmacometrics Education

Technology Services

Overview

Calculators

Exposure-Response Thresholds Multi-compartment PK Parameter Conversion

Resources

Attributions
A2-Ai

2723 S. State Street
Suite 310
Ann Arbor, MI 48104

© 2026 A2-Ai LLC. All rights reserved.